Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ohoud A. Almadani"'
Autor:
Turki A. Althunian, Bader R. Alzenaidy, Raseel A. Alroba, Ohoud A. Almadani, Fahad A. Alqahtani, Albatool A. Binajlan, Amal I. Almousa, Deema K. Alamr, Malak S. Al-Mofada, Nora Y. Alsaqer, Hessa A. Alarfaj, Abdulmohsen A. Bahlewa, Mohammed A. Alharbi, Ali M. Alhomaidan, Abdulaziz A. Alsuwyeh, Abdulmohsen A. Alsaleh
Publikováno v:
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background This retrospective analysis aimed to comprehensively review the design and regulatory aspects of bioequivalence trials submitted to the Saudi Food and Drug Authority (SFDA) since 2017. Methods This was a retrospective, comprehensi
Externí odkaz:
https://doaj.org/article/8b585f52695c43b8bf5697f601555014
Publikováno v:
Saudi Pharmaceutical Journal, Vol 30, Iss 12, Pp 1725-1735 (2022)
Background: Vaccine adverse event reporting system (VAERS) was established in the United States (U.S.) as an early warning system with a main purpose of collecting post-marketing Adverse events following immunizations (AEFIs) reports to monitor the v
Externí odkaz:
https://doaj.org/article/ad1f089405f04508977459560e190dc4
Autor:
Turki Althunian, Ohoud A. Almadani, Ghada M. Alsagri, Hisham A. Badreldin, Thamir M.Alshammari
Purpose: Optimal adherence to antidiabetics among patients with type 2 diabetes mellitus has been associated with positive health outcomes; however, studies to assess this adherence in Saudi Arabia are scarce. We aimed to evaluate adherence to antidi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa088b98b603e7d8ecf2954559ed01c6
https://doi.org/10.22541/au.168060941.11118998/v1
https://doi.org/10.22541/au.168060941.11118998/v1
Autor:
Turki Althunian, Mohammad A. Alowairdhi, Fatimah H. Alhussain, Maha I. Alomran, Ohoud A. Almadani, Norah A. Alkhammash, Shayma F. Alyabes, Sultan A. Alharbi, Esraa A. Almudaiheem, Reem A. Alhaider, Sara A. Alhassan, Zainab A. Almuallem, Nuha Algain, Abdulaziz O. Alshehri, Thamir Alshammari
Purpose: Studies suggested that drug pricing might be a risk factor for drug shortage; however, a few provided a quantitative assessment of this possible causal association. This study aimed to assess whether drug prices are associated with drug shor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e458a38fec2c10febb533b02909dd338
https://doi.org/10.22541/au.167845461.18456079/v1
https://doi.org/10.22541/au.167845461.18456079/v1